12615 Results

People

  1. Ladanyi
    Ladanyi
  2. Reuter
    Reuter
  3. Antonescu
    Antonescu
  4. Berger
    Berger
  5. Travis
    Travis
  6. Shia
    Shia
  7. Busam
    Busam
  8. Al-Ahmadie
    Al-Ahmadie
  9. Arcila
    Arcila
  10. Weigelt
    Weigelt

Groups

  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)
  7. Tow Center for Developmental Oncology (TCDO) (2643)
  8. Sloan Kettering Institute Postdocs (2500)
  9. Survivorship Research (2113)
  10. Epidemiology and Biostatistics (2024)
  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunohistochemical evaluation of FLI-1 in acute lymphoblastic lymphoma: A potential diagnostic pitfall
    Meeting Abstract

    Lin, O.; Filippa, D. A.; Teruya-Feldstein, J.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • EGFR mutations in lung adenocarcinomas: Clinical testing experience in 334 consecutive cases and relationship to EGFR gene copy number and immunohistochemical expression
    Meeting Abstract

    Li, A. R.; Chitale, D.; Riely, G. J.; Pao, W.; Ma, Y.; Zheng, T.; Miller, V. A.; Zakowski, M. F.; Rusch, V.; Kris, M. G.; more...
    Journal of Molecular Diagnostics (2007)

    Fulltext@MSK | Save
  • Role of external radiation therapy in patients with advanced or recurrent non-anaplastic thyroid cancer: The Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Lee, K. S.; Tuttle, R. M.; Ghossein, R. A.; Patel, S. G.; Shaha, A. R.; Lee, N. Y.
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save
  • Imaging-histologic discordance at MRI-guided vacuum-assisted breast biopsy
    Meeting Abstract

    Lee, J.; Murray, M. P.; Liberman, L.
    American Journal of Roentgenology (2007)

    Fulltext@MSK | Save
  • Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Lack of desmoglein 2 is an indicator of cancer progression and a poor prognostic factor in stage 1 non-small cell lung cancer
    Meeting Abstract

    Kamatani, H.; Kumagai, N.; Tanaka, T.; Kawamura, S.; Hewitt, S. M.; Franks, T. J.; Travis, W. D.; Jen, J.; Fukuoka, J.
    Modern Pathology (2007)

    Fulltext@MSK | Save
  • Lack of desmoglein 2 is an indicator of cancer progression and a poor prognostic factor in stage 1 non-small cell lung cancer
    Meeting Abstract

    Kamatani, H.; Kumagai, N.; Tanaka, T.; Kawamura, S.; Hewitt, S. M.; Franks, T. J.; Travis, W. D.; Jen, J.; Fukuoka, J.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • Analysis of monoclonal antibodies (mAbs) to tyrosinase related protein-1 (trp-1) as diagnostic reagents in surgical pathology
    Meeting Abstract

    Jungbluth, A. A.; Behrendt, N.; Castelli, S.; Frosina, D.; Zaidi, B.; Busam, K. J.
    Pathology Research and Practice (2007)

    Fulltext@MSK | Save
  • Insulin-like growth factor 2 expression in colorectal cancer
    Meeting Abstract

    Idrees, K.; Park, S. H.; Shia, J.; Cheng, Y. W.; Shattock, R.; Khan, S.; Zeng, Z.; Notterman, D.; Barany, F.; Paty, P. B.
    Annals of Surgical Oncology (2007)

    Fulltext@MSK | Save
  • Morphologic assessment of bladder carcinomas in cystectomy specimens post neoadjuvant chemotherapy
    Meeting Abstract

    Harik, L. R.; Olgac, S.; Tickoo, S. K.; Al-Ahmadie, H.; Fine, S. W.; Gopalan, A.; Reuter, V. E.
    Modern Pathology (2007)

    Fulltext@MSK | Save